Back to Alzheimers Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01993836

NCT01993836
Completed Phase 4

Who may be able to join

Who might be able to join this trial:

  • You are 60 years of age or older and are having surgery
  • Your surgery is expected to last at least 2 hours, including the time needed for preparation and anesthesia
  • You are able to speak and understand English
  • You are able to understand and sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • You are currently in prison or a correctional facility
  • You are pregnant
  • You or a close family member have been diagnosed with or are suspected of having a condition called malignant hyperthermia (a serious reaction to certain anesthesia medications — confirm with trial site)
  • You are unable to receive either of the two anesthesia medications used in this trial (propofol or isoflurane) because of an allergy or another medical reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 4: approximately Approved of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 4
Sponsor
Duke University
Registry
clinicaltrials_gov
Start date
1 November 2013
Est. completion
10 January 2019

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Correlation Between Perioperative Change in Cerebrospinal Fluid (CSF) Markers of Alzheimers Disease and Perioperative Cognitive Change; Correlation Between Perioperative Change in Ratios of Cerebrospinal Fluid (CSF) Markers of Alzheimers Disease and Perioperative Cognitive Change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov